Long presents peer-reviewed NYC Care outcome studies

Oh, don't worry.

I have all the data for you here.

I was waiting for that question.

So we've taken it upon ourselves, given that the program we now have several years of experience in it, to actually do rigorous research on it and publish it in peer-reviewed national journals.

So there's two publications I'll just quickly outline for you that I think paint the picture of the impact NYC Cares had.

The first question we had was among those that enroll in NYC care, what proportion of them have an improvement in their chronic disease?

Oftentimes, these are people, in my example I gave earlier, that haven't seen a doctor in a very long time.

My patient hasn't seen a doctor in 43 years.

What can she expect if I tell her she has diabetes or high blood pressure?

The answer to that is yes.

Question is, 73% of our new enrollees that we diagnose with hypertension in their first visit have a significant improvement within the first six months, which we think is very remarkable.

53% of our patients that we diagnose with diabetes have a significant improvement in the first six months too.

So we know the program is having a big impact on people that had many times undiagnosed conditions before.

The next question is, okay, so then what happens over time?

How do they compare to the rest of our patients too?

So the first publication, by the way, was in the Journal of Public Health Management and Practice in 2024.

This next one, which I'm particularly excited to tell you about, is published in one of the major journals, Journal of General Internal Medicine, in 2025, so just last year.

What we did is we compared a new NYC care enrollee to a new Medicaid enrollee.

So new versus new, not somebody that's been in care for 20 years, new patient versus new patient.

First question is, for diabetes and hypertension, is there a difference if you enroll in NYC care versus if you enroll in Medicaid?

The answer to that question, no difference at all.

Authentical outcome.

So if you enroll in either program,

we have the same chance of getting your chronic disease under good control.

Interestingly, we even saw a signal, so it was statistically significant, but this is just one study, that patients in NYC care actually had a lower hospital admission rate than new patients in Medicaid.

So all of that we take to say that we view the NYC care as having a clear impact once you enroll.

and it's sustained, achieving the same chronic disease outcomes as patients that are new in Medicaid, maybe even slightly better in some ways.

And if you translate that in terms of the data that's out there about if you have insurance, the lives that are saved, the NYC Care Program to date has saved 1,569 lives.